WELCOME TO COVIDHOMEO - A DATABASE OF HOMEOPATHY FOR COVID-19!

Almost the whole world is suffering from pandemic known as COVID-19 by one or the other way, irrespective of economic, technologic, weapon, political advantages they have. Homeopathic remedies have been used as prophylactic to prevent the epidemic since centuries. This site gives information on homeopathy in respect to COVID-19.

Tracing the history it was Hahnemann who first applied the genus epidemicus in 1799 during a scarlet fever epidemic he treated in the German town Königslutter. It is an interesting story that how how Dr. Hahnemann had accidentally discovered the genus epidemicus. A few members of large family with scarlet fever approached Dr. Hahnemann for treatment. He noticed that a child already under the doses Belladonna for other problem did not develop symptoms of scarlet fever. That was the moment he discovered Belladonna as a prophylactic for the entire family which he administered to all of them. Hahnemann concluded that a remedy that rapidly cures at the onset of an illness would be the best preventative.

Homeopathy was successfully applied during the epidemic of Spanish flu in 1918-19, where around 20 million people died globally. Mortality rate in homeopathic treated population was 1-2%, whereas it was 30-60% in people treated by conventional physicians. Chikungunya, dengue fever, acute encephalitis/japanese encephalitis, cholera and dengue were also successfully managed with homeopathy.

Recenlty Ministry of AYUSH, Government of India has published the recommendation of Expert Committee constituted by CCRH for the using of Arsenicum album 30CH as Genus epidemicus for prevention. Following that, many governments and autonomous bodies under different governments have used this as prophylactic. Apart from that, many other stalwarts have suggested possible role of other drugs in the current situation. A group of homeopaths from Italy have published an observational study of confirmed or suspected COVID-19 patients. None of the patients was required hospitalization.

This site contains database on homeoeopathy in respect to COVID-19.

COVID Centre started at Lord Mahavira Homeo College, Ludhiana by Ludhiana IMA

 

Specialist doctors, medical officers, nurses, ward boys, technicians, sweepers and other staff have been hired to ensure the centre’s smooth functioning, with all expenses paid by IMA Ludhiana

Doctors of the Indian Medical Association (IMA) Ludhiana have set up a Covid care centre at the Lord Mahavira Homeopathic Medical College and Hospital on Hambran Road here.

While inaugurating the centre on Sunday, Punjab cabinet minister Bharat Bhushan Ashu thanked IMA Ludhiana and the Lord Mahavira Hospital management for assisting the district administration at “this hour of need”.

Ashu, who was also accompanied by deputy commissioner Varinder Kumar Sharma and others, said he was talking to private hospitals to take over government hospitals to provide quality healthcare facilities to local residents.

Even though a number of people from other districts were coming for treatment to Ludhiana, Ashu assured the locals that there was no shortage of beds in the city and urged them to visit the nearest hospital if they suspected they had contracted Covid-19.

Dr Sunil Katyal, president, IMA Ludhiana, informed that to start with the Covid centre would have 25 beds, which would be upgraded to 50 beds later.

Specialist doctors, medical officers, nurses, ward boys, technicians, sweepers and other staff had been hired to ensure its smooth functioning, with all expenses paid by IMA Ludhiana. The entire hospital would be sanitised daily and Covid samples would also be taken here, Katyal added.

Speaking on the occasion, DC  Sharma said that people from all sections of the society should contribute to help others during the pandemic, He also urged other social organisations to come forward and set up such centres and assured all possible help from the district administration to do so.

Source: https://www.hindustantimes.com/chandigarh/ima-ludhiana-docs-start-covid-hospital-at-lord-mahavira-homeo-college/story-Oh2a50sv6q3qTtD5aD3K8M.html

Homeo doctor from Mahabubabad hits the road in fight against Covid

 

With the covid-19 crisis pandemic showing no signs of abating, this homeopathy doctor, in the course of his mission, has been reaching out to the masses, educating and trying to make them immune to coronavirus


Yellandu (Kothagudem): He is a man on a mission, having travelled 4,400 kms covering 17 districts of Telangana State in 84 days, distributed homeopathic medicine to 86,000 people so far, and continues with the same zeal he had on April 22 when he set out from home in Mahabubabad.

With the covid-19 crisis pandemic showing no signs of abating, this homeopathy doctor, in the course of his mission, has been reaching out to the masses, educating and trying to make them immune to coronavirus.

Meet Dr. Parikipandla Ashok, who has been touring towns and villages in the State, unmindful of the fact that he was passing through Covid-19 hotspots, administering ‘Arsenicum Album 30,’ an immunity boosting homeopathic medicine to fight the virus. He is also the state president of Homeopathic Medical Association.

Dr Ashok has also been distributing pamphlets creating awareness on precautionary measures to keep oneself safe from the virus. He launched his mission, ‘Praja Chaitanya Yatra,’ on April 22 and has visited 114 mandals in 17 districts across the State riding his motorbike, taking a break after each district visit.

Speaking to Telangana Today at Yellandu in the district, Dr. Ashok said Bhadradri Kothagudem was the 17th district he visited as part of his yatra to distribute the homeo medicines to locals. He said he got nearly 50,000 pamphlets printed with covid-19 safety measures.

‘Covid-19 crisis has affected everyone, and as a doctor, I just wanted to do my part to fight this crisis and took up the yatra’, he said, adding: ‘After covering erstwhile Khammam district, I am planning to tour Siddipet. It is my wish to cover 5,000 kms and distribute Arsenicum Album 30 to one lakh people,” he said, adding that he has spent around Rs one lakh on his mission so far.

With the help of elected members in places where he goes, Dr Ashok has also been organising meetings to educate the public on the measures to be taken to protect themselves from the pandemic. Such meetings have been held in 1,320 places so far.

Arsenicum Album 30 is the best bet

Explaining the efficacy of Arsenicum Album 30, Dr. Ashok says the medicine does not guarantee that a person will not get infected with the virus. But it certainly assists an individual fight the virus and in fast recovery.

“I am a living example of homeo medicine’s efficacy. I take one dose of the medicine once in 15 days and I got tested six times and every time I was tested negative, despite the fact that I have been visiting the places where covid-19 cases are rampant,” he noted.

In Gujarat, Arsenicum Album 30 was given to a group of 3,000 persons on an experimental basis and it was found to have strengthened their immune system. Then the State government started distributing the homeo medicine to the public. Maharashtra government is also doing the same, he said.

The Union AYUSH Department has also prescribed the medicine, Dr. Ashok said, adding he had written letters to Governor Tamilisai Soundararajan, Chief Minister K Chandrashekhar Rao and Health Minister Eatala Rajender urging them to officially distribute Arsenicum Album 30 to the public.

“Just waiting for the vaccine to be released is not going to do any good. We need to have a holistic approach to address the coronavirus crisis. Ayurveda, yoga, healthy food habits have to be promoted to fight the virus” he added.


Source: https://telanganatoday.com/homeo-doctor-from-mahabubabad-hits-the-road-in-fight-against-covid

Mini Homeopathic Repertory for COVID-19

 

Collecting clinical experience of homeopathic support in COVID-19

Eleventh issue

LMHI newsletter                                                                                                                 

10  June 2020

 

Testing the mini-repertory app

In the previous newsletter (tenth issue) we presented a new mini-repertory for COVID-19 like illness, regarding the three most prescribed homeopathic medicines: Arsenicum album (ars), Bryonia (bry) and Gelsemium (gels). The repertorisation algorithm was based on Bayes’ theorem and likelihood ratio (LR). The advantage of LR (= (prevalence in medicine population) / (prevalence in remainder of the population) is that it discriminates between medicines better than in our well-known repertories. Some of the symptoms with their LRs are shown in Table 1.

The app supporting the repertorisation for symptoms in the mini-repertory is available at the website address https://hpra.co.uk/.

Table 1: occurrence of four symptoms in the research population of 161 patients and in populations responding well to Arsenicum album (ars), Bryonia (bry) and Gelsemium (gels), with the corresponding LRs.

Symptoms

Count

ars

LRars

bry

LRbry

gels

LRgels

n=

161

21

 

45

 

25

 

fatigue

87

11

0.96

20

0.77

20

1.62

dry cough

73

8

0.82

26

1.43

10

0.86

dyspnea

51

5

0.72

18

1.41

4

0.46

headache

48

6

0.95

17

1.41

9

1.26

 

An example demonstrates the difference which LR makes: the symptom ‘fatigue’ was present in 87 out of all 161 cases, and in 11 out of 21 ars cases, in 20 out of 45 bry cases and in 20 out of 25 gels cases. In the existing repertory this would have resulted in bold entries for all three medicines under the rubric ‘Fatigue in COVID-19’. In the Bayesian repertory we see LR= 1.62 for gels and LR=0.77 for bry. This can be understood as a slight confirmation for gels if the symptom is present and a slight contra-indication for bry. Such differences can be demonstrated only by noting the same symptom in a considerable number of cases who responded well to the same medicine.

The homeopathic principle that one symptom, or a diagnosis, is insufficient to choose a homeopathic medicine accurately is even more relevant for common symptoms. Using the existing repertory, the combination of the symptoms ‘fatigue’ and ‘headache’ would not give us any indication of the appropriate medicine. Only after finding a keynote symptom for gels, like ‘Chill running up and down the back’, we would say: “Yes, headache and fatigue confirm gels”. To be able to demonstrate that the combination of fatigue and headache indicates, say, gels more than ars, we would start by asking for symptoms that confirm gels, like ‘chill running up and down the back’, or we might observe that the patient can hardly keep his eyes open.

The Bayesian repertory enables better use of common – and therefore relatively unimportant – symptoms. LR shows small but clinically relevant differences between medicines which have the same typology in the standard repertory, and a combination of such common symptoms can result in larger differences between medicines. To give an example: the combination of ‘fatigue’ plus ‘headache’ results in a combined LR= 1.62 x 1.26 = 2.04 for gels and LR= 0.96 x 0.95 = 0.91 for ars. The combined LR for gels now becomes more than twice as large for gels than for ars.

With this procedure we can take a combination of formerly quite useless symptoms and turn this into a meaningful indication for specific medicines. This is especially useful if the patient has no symptoms that clearly indicate a specific medicine. The downside of LR, however, is that we have to make the necessary calculations. This is easily performed in a computerised repertory, but where this is not available we can use the app mentioned above.

The app contains the 20 most frequently occurring symptoms from a collection of 161 COVID-19 cases. It calculates combined LRs for specific medicines from a selection of these symptoms. Currently, the app can differentiate between only three medicines: ars, bry and gels. Other medicines and other symptoms can be added when enough cases have been gathered. One symptom we would like to add is ‘loss of taste and/or smell’, because this is a typical COVID-19 symptom, but the data we have so far do not yet show a clear difference between medicines.

Testing the app with real cases

Recently, a collection of case studies involving COVID-19 was published with 18 cases; these responded well to ars (one case), bry (four cases), gels (12 cases) and Eupatorium perfoliatum (eup-p) (one case).[1] The cases were presented with clear descriptions of background, symptomatology and outcome. This, as well as the fact that all cases except one responded to the medicines present in the app, offered an opportunity to test the app with the symptoms seen in these cases.

The advantage of frequently occurring symptoms is that many patients have such symptoms. The disadvantage is that precisely this fact also causes the medicines to be less well differentiated. The clinical database we have so far contains 87 patients with ‘fatigue’ spread over the 36 medicines prescribed in 161 cases. The symptom ‘fatigue, cannot keep his eye open’, however, occurs in only 4 cases, all of which are gels.

For a first screening, e.g. with a standard questionnaire, the symptom ‘fatigue’ would be more useful than ‘fatigue, cannot keep his eyes open’ because the first occurs 22 times more frequently than the latter. On the other hand, a first screening is useful only if it indicates specific medicines that can be explored further.

However, it is vital that the first screening does not lead us in the wrong direction. To check this we need confirmed cases with an adequate number of common symptoms, combined with more specific symptoms that give a clear picture of the effective medicine. The common symptoms available in the app can be entered into this, and the output of the app should not contradict the recommendation that results from a full analysis of the case.

The question was: does the use of only the most frequently occurring symptoms in an initial screening give results that are consistent with the outcome of the standard homeopathic method using all available symptoms, general and particular?

How it works can be shown by case HK1.1. The observed symptoms were:

1.       Slow onset and progression of symptoms.

2.       Feeling irritable from the cough; does not want to talk to anyone. Prefers to be alone.

3.       Obvious increase in thirst with desire to drink warm water in large quantity.

4.       Generally ameliorated after perspiration.

5.       Mainly dry cough, with very occasional greenish sputum.

6.       Extremely bad pulsating temple headache and middle chest pain aggravated from coughing.

7.       Cough aggravated by talking and lying down, and after waking up in the morning.

8.       Cough associated with tickling feeling in the throat, ameliorated by warm drinks.

Out of these 5 symptoms could be found in the app:

1.       Thirst

2.       Dry cough

3.       Headache

4.       Chest pain < cough

5.       Cough < talking

The outcome of the app was “Strong indication for Bryonia” and this was indeed the medicine that was prescribed. An experienced homeopathic practitioner will recognise the medicine at first sight because of symptoms like ‘irritable from cough’, ‘aversion to company’, ‘thirst for large quantities’ and ‘headache from cough’, which are not in the app. However, with the combination of symptoms ‘thirst’, ‘dry cough’ and ‘headache’ the app would already have returned a “Moderate indication for Bryonia”. This results from the following LRs for bry: LR=3.31 for thirst; LR=1.43 for dry cough and LR=1.41 for headache. The combined LR for these three symptoms is 3.31 x 1.43 x 1.41 = 6.67, high enough for a ‘moderate indication’. ‘Chest pain < cough’ adds LR=3.61 and ‘Cough < talking’ LR=1.47, rendering a combined LR=35.4, representing a strong indication.

The outcome of all cases is shown in Table 2. If the combined LR of the selected symptoms was between 3 and 6, the indication was ‘slight’; if the combined LR was between 6 and 10, the indication was ‘moderate’ and if combined LR>10, the indication was ‘strong’.

Table 2: advice e of the app after entering the symptoms available in 18 cases. The ‘Nr case symptoms’ is the number of symptoms described for each case. ‘Nr app symptoms’ is the number of these symptoms available in the app. ‘App advised medicine’ represents the advice of the app with intensity.

Case

prescribed medicine

Nr case symptoms

Nr app symptoms

App advised medicine

HK1.1

bry

8

5

bry (strong)

HK2.1

bry

12

5

bry (slight)

HK3.1

bry

18

6

bry (strong)

HK3.2

gels

14

5

gels (strong), bry (slight)

HK3.3

gels

11

4

gels (moderate)

HK3.4

gels

12

3

gels (strong)

HK3.5

gels

12

6

gels (strong), bry (slight)

HK4.1

gels

5

4

gels (strong)

HK4.2

gels

5

4

gels (slight), bry (slight)

HK4.3

ars

5

4

ars (slight), gels (slight)

HK4.4

gels

5

4

gels (moderate)

HK4.5

gels

7

4

gels (strong)

HK5.1

gels

8

4

gels (strong)

HK5.2

bry

9

6

bry (moderate), gels (moderate)

HK5.3

gels

6

3

bry (slight)

HK5.4

gels

6

3

bry (slight)

HK5.5

eup-p

4

4

bry (slight), gels (slight)

HK6.1

bry

21

10

bry (strong)

 

Discussion

This set of cases contained only one case (HK5.5) that could not be handled by the app, because it contained no data for that particular medicine (eup-p). In this case, the app gave only slight indications, but did not contradict the choice based on a full homeopathic evaluation by offering a moderate or strong indication for one of its own medicines.

In the remaining 17 cases, for 11 (65%) the recommendation of the app was entirely consistent with the full homeopathic evaluation, giving a moderate or strong indication for the prescribed medicine. In one case (HK5.2), a second medicine came up to the same degree; in this case, a specific symptom, ‘coldness up and down the back’ (not available in the app), clarified the choice of gels. In three cases (HK2.1, HK4.2, HK4.3) the recommendation was consistent but with only a slight indication; it did not, though, contradict the definitive choice. In these cases, the full evaluation clarified the choice because specific symptoms indicated the correct medicine. In two cases (HK5.3, HK5.4), the recommendation of the app slightly contraindicated the correct choice which was made on the basis of specific symptoms, such as ‘Heaviness of the eyelids’, which clearly indicated the relevant medicine.

Our results confirm that the app can be useful where there are no specific symptoms and that the most frequently occurring symptoms can give useful indications for medicine selection in COVID-19 cases. The app can be used as an addition to a full homeopathic consultation and evaluation of symptoms.

There is another potential application for this app. Suppose you encounter a new outbreak of COVID-19 disease and the number of cases is more than you can handle. In this case, an inexperienced practitioner (or homeopathic student) could carry out the first screening with the app and an experienced practitioner could do any necessary additional homeopathic consultation. This would save a lot of time.

As we collect more cases, the app can be extended with more medicines and more symptoms. It will also be possible to fine-tune the output of the app by changing cut-off values for specific recommendations.


How to improve the app further?

We hope that our newsletters will encourage you to use the app to see what value it has. Naturally, you will want to see more medicines in the app, but this can only be achieved with your help, with your cases.

Remember that we are not trying to prove anything with this research, we want to improve our practice! In any case you submit, you should be satisfied that one specific homeopathic medicine was responsible for the improvement. Try to explain why this was the case.

We summarise below the minimum data necessary for this project. We already had:

-          Severity of COVID-19 illness:  Mild – Moderate – Severe – critical

-          Is COVID-19 confirmed?

-          Medicine, with date of first intake

-          Number of hours until onset of improvement and/or until absence of fever after the start of the medicine

-          If possible at least 3-5 symptoms that were characteristic for the case

-          Pneumonia on X-ray or CAT

 

Also check:

-          Onset of complaints: how many hours/days between first symptoms and the moment the disease aggravated

-          Fatigue/prostration/exhaustion; where is the weakness located

-          Fear/anxiety

-          Restlessness

-          Fever, chill, or chill alternating with fever

-          Thirst

-          Pain; where

-          Cough dry or moist

-          Dyspnea

-          Throat pain

-          Loss of taste and/or smell

-         diarrhoea

 

The LMHI COVID-19 case collection team:
Lex Rutten, Bernardo Merizalde, Robbert van Haselen, Raj Kumar Manchanda, Ashley Ross, Gustavo Cataldi, Altunay Agaoglu, Tiziana di Giampietro, Lefteris Tapakis, Theodore Lilas, Peter Gold, Frederik Schroyens, José Eizayaga

References



[1] To, Ka Lun Aaron; Fok YYY. Homeopathic Clinical Features of 18 Patients in COVID-19 Outbreaks in Hong Kong. Homeopathy. 2020;109.

Source: https://www.lmhi.org/Documents/News/Collecting%20clinical%20case%20newsletter%20nr_11.docx

To access the mini-repertorisation app: https://hpra.co.uk/